These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 93586)

  • 1. Enhancement of feline leukemia virus-induced leukemogenesis in cats exposed to methylnitrosourea.
    Schaller JP; Mathes LE; Hoover EA; Olsen RG
    Int J Cancer; 1979 Nov; 24(5):700-5. PubMed ID: 93586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feline leukemia virus infection: age-related variation in response of cats to experimental infection.
    Hoover EA; Olsen RG; Hardy WD; Schaller JP; Mathes LE
    J Natl Cancer Inst; 1976 Aug; 57(2):365-9. PubMed ID: 187771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feline oncornavirus-associated cell membrane antigen: a viral and not a cellularly coded transformation-specific antigen of cat lymphomas.
    Vedbrat SS; Rasheed S; Lutz H; Gonda MA; Ruscetti S; Gardner MB; Prensky W
    Virology; 1983 Jan; 124(2):445-61. PubMed ID: 6186079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Course of feline leukemia virus infection and its detection by enzyme-linked immunosorbent assay and monoclonal antibodies.
    Lutz H; Pedersen NC; Theilen GH
    Am J Vet Res; 1983 Nov; 44(11):2054-9. PubMed ID: 6316819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The feline oncornavirus-associated cell membrane antigen (FOCMA) is related to, but distinguishable from, FeLV-C gp70.
    Snyder HW; Singhal MC; Zuckerman EE; Jones FR; Hardy WD
    Virology; 1983 Dec; 131(2):315-27. PubMed ID: 6318434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between feline leukemia virus antigen expression and viral infectivity in blood, bone marrow, and saliva of cats.
    Hoover EA; Olsen RG; Mathes LE; Schaller JP
    Cancer Res; 1977 Oct; 37(10):3707-10. PubMed ID: 198120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feline oncornavirus-associated cell membrane antigen. III. Antibody titers in cats from leukemia cluster households.
    Essex M; Jakowski RM; Hardy WD; Cotter SM; Hess P; Sliski A
    J Natl Cancer Inst; 1975 Mar; 54(3):637-41. PubMed ID: 164563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells.
    Grant CK; de Noronha F; Tusch C; Michalek MT; McLane MF
    J Natl Cancer Inst; 1980 Dec; 65(6):1285-92. PubMed ID: 6253714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Horizontal transmission of feline leukemia virus under natural conditions in a feline leukemia cluster household.
    Essex M; Cotter SM; Sliski AH; Hardy WD; Stephenson JR; Aaronson SA; Jarrett O
    Int J Cancer; 1977 Jan; 19(1):90-6. PubMed ID: 188773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection with feline leukemia virus associated with induction of humoral response to a normal cell protein.
    Chen AP; Essex ME
    Cancer Invest; 1984; 2(2):81-90. PubMed ID: 6329486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination against feline leukaemia virus using a cell membrane antigen system.
    Jarrett W; Jarrett O; Mackey L; Laird H; Hood C; Hay D
    Int J Cancer; 1975 Jul; 16(1):134-41. PubMed ID: 170211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural feline leukemia virus infection and the immune response of cats of different ages.
    Grant CK; Essex M; Gardner MB; Hardy WD
    Cancer Res; 1980 Mar; 40(3):823-9. PubMed ID: 6258787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feline oncornavirus-associated cell membrane antigen. VI. Cytotoxic antibody in cats exposed to feline leukemia virus.
    Mathes LE; Yohn DS; Hoover EA; Essex M; Schaller JP; Olsen RG
    J Natl Cancer Inst; 1976 Jun; 56(6):1197-200. PubMed ID: 186623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feline oncornavirus-associated cell membrane antigen. IV. Antibody titers in cats with naturally occurring leukemia, lymphoma, and other diseases.
    Essex M; Cotter SM; Hardy WD; Hess P; Jarrett W; Jarrett O; Mackey L; Laird H; Perryman L; Olsen RG; Yohn DS
    J Natl Cancer Inst; 1975 Aug; 55(2):463-7. PubMed ID: 169377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feline oncornavirus-associated cell-membrane antigen (FOCMA): distinction between FOCMA and the major virion glycoprotein.
    Stephenson JR; Essex M; Hino S; Hardy WD; Aaronson SA
    Proc Natl Acad Sci U S A; 1977 Mar; 74(3):1219-23. PubMed ID: 191832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of susceptibility and resistance to feline leukemia virus infection. II. Susceptibility of feline lymphocytes to productive feline leukemia virus infection.
    Rojko JL; Hoover EA; Finn BL; Olsen RG
    J Natl Cancer Inst; 1981 Oct; 67(4):899-910. PubMed ID: 6268886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of feline leukemia virus immunity.
    Charreyre C; Pedersen NC
    J Am Vet Med Assoc; 1991 Nov; 199(10):1316-24. PubMed ID: 1666074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased susceptibility to feline leukemia virus infection in cats exposed to methylnitrosourea.
    Schaller JP; Mathes LE; Hoover EA; Koestner A; Olsen RG
    Cancer Res; 1978 Apr; 38(4):996-8. PubMed ID: 205356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural immunity in cats to feline leukemia viral antigens.
    Ruscetti SK; Parks WP
    J Immunol; 1976 Nov; 117(5 Pt.2):2029-35. PubMed ID: 186536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of feline leukemia virus with lymphosarcoma and other disorders in the cat.
    Cotter SM; Hardy WD; Essex M
    J Am Vet Med Assoc; 1975 Mar; 166(5):449-54. PubMed ID: 163223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.